| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1399-5618.2005.00235.X |
| P698 | PubMed publication ID | 16026484 |
| P2093 | author name string | David L Dunner | |
| P2860 | cites work | Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults | Q28131763 |
| Clinical factors associated with treatment noncompliance in euthymic bipolar patients | Q28138392 | ||
| The role of atypical antipsychotics in bipolar depression and anxiety disorders | Q28236713 | ||
| Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study | Q28259349 | ||
| Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders | Q28269677 | ||
| A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder | Q29394100 | ||
| Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 | Q29614193 | ||
| New onset diabetes and atypical antipsychotics | Q32066029 | ||
| Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...] | Q33202376 | ||
| Effects of lamotrigine on nocturnal sleep, daytime somnolence and cognitive functions in focal epilepsy. | Q33914510 | ||
| A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders | Q33927263 | ||
| What is a "mood stabilizer"? An evidence-based response | Q33974918 | ||
| Severe weight gain induced by combination treatment with risperidone and paroxetine | Q34157168 | ||
| Zonisamide for weight loss in obese adults: a randomized controlled trial | Q34189386 | ||
| Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression | Q34275783 | ||
| Antidepressants for bipolar depression: a systematic review of randomized, controlled trials | Q34344394 | ||
| Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis | Q34352552 | ||
| Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics | Q44299750 | ||
| Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial | Q44299951 | ||
| Pregabalin in generalized anxiety disorder: a placebo-controlled trial | Q44336408 | ||
| The effects of adjunctive topiramate on cognitive function in patients with epilepsy | Q44339970 | ||
| Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial | Q44385585 | ||
| A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder | Q44403599 | ||
| Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials | Q44428863 | ||
| Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand | Q44428876 | ||
| Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial | Q44476520 | ||
| A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder | Q44491691 | ||
| Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses | Q44507215 | ||
| Antipsychotic-induced weight gain: bipolar disorder and leptin | Q44550771 | ||
| Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine | Q44551305 | ||
| Oral contraceptives reduce lamotrigine plasma levels | Q44562274 | ||
| A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 | ||
| Suicide risk in bipolar disorder during treatment with lithium and divalproex | Q44586528 | ||
| A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania | Q44684784 | ||
| A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy | Q44731832 | ||
| Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic | Q45220527 | ||
| Menstrual cycle related mood changes in women with bipolar disorder | Q46396389 | ||
| Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. | Q51092078 | ||
| A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. | Q51102701 | ||
| Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. | Q51570964 | ||
| Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. | Q51943686 | ||
| A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure. | Q53512831 | ||
| An open label study of gabapentin in the treatment of acute mania. | Q53943806 | ||
| The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania. | Q54027554 | ||
| Efficacy and safety of zonisamide: results of a multicenter study. | Q54052097 | ||
| Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients. | Q54059965 | ||
| Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder | Q56138336 | ||
| A systematic review of the safety profile of levetiracetam: a new antiepileptic drug. | Q34416450 | ||
| New antiepileptic drugs: review on drug interactions | Q34503324 | ||
| The expanding pharmacopoeia for bipolar disorder | Q34511503 | ||
| Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group | Q34514128 | ||
| Mood stabilizer combinations: a review of safety and efficacy | Q34744469 | ||
| Efficacy and safety of novel antipsychotics: a critical review | Q34982556 | ||
| Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review | Q35014566 | ||
| Aripiprazole: profile on efficacy and safety | Q35020547 | ||
| The Maudsley bipolar disorder project. A survey of psychotropic prescribing patterns in bipolar I disorder | Q35041599 | ||
| Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: a review of efficacy and tolerability | Q35067640 | ||
| Combination treatment in bipolar disorder: a review of controlled trials | Q35142745 | ||
| Risperidone-associated diabetes mellitus: a pharmacovigilance study | Q35160244 | ||
| Newer antiepileptic drugs and cognitive issues | Q35161333 | ||
| Clozapine: a clinical review of adverse effects and management | Q35168488 | ||
| Antipsychotic drugs in bipolar disorder | Q35219400 | ||
| Cognitive effects of atypical antipsychotics: focus on bipolar spectrum disorders | Q35618437 | ||
| Topiramate in Bipolar and Schizoaffective Disorders: Weight Loss and Efficacy | Q35665140 | ||
| New anticonvulsant medication uses in bipolar disorder | Q35673095 | ||
| Acute granulomatous interstitial nephritis and colitis in anticonvulsant hypersensitivity syndrome associated with lamotrigine treatment | Q40612854 | ||
| The effect of alcohol and substance abuse on the course of bipolar affective disorder | Q41017655 | ||
| Open maintenance treatment of bipolar disorder spectrum patients who responded to gabapentin augmentation in the acute phase of treatment | Q41713302 | ||
| Clozapine-related seizures: experience with 5,629 patients | Q42282949 | ||
| A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group | Q42626284 | ||
| Clozapine in the treatment of refractory psychotic mania | Q42627098 | ||
| Postmarketing experience with topiramate and cognition | Q42660595 | ||
| Tiagabine in treatment refractory bipolar disorder: a clinical case series. | Q42690598 | ||
| Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group | Q43507067 | ||
| Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series | Q43608273 | ||
| Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults | Q43650818 | ||
| Altered ovarian function and cardiovascular risk factors in valproate-treated women | Q43744359 | ||
| Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder | Q43761129 | ||
| A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study | Q43840719 | ||
| Olanzapine-induced diabetic ketoacidosis | Q43856251 | ||
| Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers. | Q43906079 | ||
| Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers | Q44004463 | ||
| Olanzapine versus divalproex in the treatment of acute mania | Q44013092 | ||
| Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder | Q44013096 | ||
| Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety | Q44045819 | ||
| Use of topiramate in treatment-resistant bipolar spectrum disorders. | Q44097703 | ||
| A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania | Q44168457 | ||
| Safety and tolerability: how do newer generation "atypical" antipsychotics compare? | Q44206342 | ||
| An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients | Q44206750 | ||
| Obesity as a correlate of outcome in patients with bipolar I disorder | Q44265285 | ||
| Antipsychotic-induced type 2 diabetes: evidence from a large health plan database | Q44288625 | ||
| P433 | issue | 4 | |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 307-325 | |
| P577 | publication date | 2005-08-01 | |
| P1433 | published in | Bipolar Disorders | Q15716681 |
| P1476 | title | Safety and tolerability of emerging pharmacological treatments for bipolar disorder | |
| P478 | volume | 7 |
| Q34614432 | Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review. |
| Q38003196 | Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder |
| Q50541776 | Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid. |
| Q36519345 | Economics of atypical antipsychotics in bipolar disorder: a review of the literature |
| Q34593776 | Efficacy and tolerability of pharmacotherapies for borderline personality disorder |
| Q34578220 | High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients. |
| Q81591299 | Managing bipolar disorder from urgent situations to maintenance therapy |
| Q36166185 | Oxcarbazepine as monotherapy of acute mania in insufficiently controlled type-1 diabetes mellitus: a case-report |
| Q44017165 | Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania |
| Q79366412 | Retinal function and histopathology in rabbits treated with Topiramate |
| Q34595255 | Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study |
| Q37858609 | Study design and patient characteristics and outcome in acute mania clinical trials |
| Q28744504 | The effectiveness of anticonvulsants in psychiatric disorders |
| Q36784587 | The increasing frequency of mania and bipolar disorder: causes and potential negative impacts. |
| Q43168355 | The long-term effectiveness of clozapine and lamotrigine in a patient with treatment-resistant rapid-cycling bipolar disorder |
| Q37076060 | The neuropharmacology of psychosis |
| Q37429721 | Treating bipolar disorder in the primary care setting: the role of aripiprazole |
| Q37067704 | Weight gain and metabolic issues of medicines used for bipolar disorder |
| Q83866936 | Ziprasidone in bipolar disorder |
Search more.